Figure S5. Spatial transcriptome and spatial trajectory of malignant EPCs_8 and CXCL1⁺ CAFs. (A–C) Spatial feature plot displaying possible expression distributions of BHLHE40, SMAD3, and SMAD4. (D) Cluster plot of 0–15 subgroups clustered by K-means. (E–G) Spatial feature plot displaying possible expression distributions of malignant EPCs_8, CXCL1⁺ CAFs, and SFRP2⁺ CAFs in another sample predicted by SPOTlight. (H) Spatial feature plot displaying possible expression distributions of BHLHE40 in another sample. (I) Possible spatial differentiation trajectory from malignant EPCs_8 to CXCL1⁺ CAFs in another sample.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: